Shopping Cart

Your shopping cart is currently empty

Norswertianolin

Name: Norswertianolin
Brand: TargetMol
SKU: T40629
Price: 147 USD
Availability: InStock
Rating: 5 (10 reviews)

😃Good

Catalog No. T40629Cas No. 54954-12-0

Norswertianolin, a compound isolated from G. acuta, is a small molecule activator of CSE, which enhances the H-generation 2S activity of CSE and can be used in the study of cardiovascular diseases.

Norswertianolin

😃Good

Purity: 98.06%

Catalog No. T40629Cas No. 54954-12-0

Norswertianolin, a compound isolated from G. acuta, is a small molecule activator of CSE, which enhances the H-generation 2S activity of CSE and can be used in the study of cardiovascular diseases.

Pack Size	Price	USA Warehouse	Global Warehouse
1 mg	$147	-	In Stock
5 mg	$378	-	In Stock
10 mg	$612	-	In Stock
25 mg	$953	-	In Stock
50 mg	$1,280	-	In Stock

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Batch Information

Select Batch

Purity:98.06%

Appearance:Solid

Color:Yellow

Resource Download

COA HNMR HPLC

Product Introduction

Bioactivity

Description	Norswertianolin, a compound isolated from G. acuta, is a small molecule activator of CSE, which enhances the H-generation 2S activity of CSE and can be used in the study of cardiovascular diseases.
In vitro	Norswertianolin (3.125-50 μM) was able to protect against H2O2-induced damage in H9c2 cells. In addition, Norswertianolin significantly increased the transcript levels of HO-1 and GCLC in H9c2 cells. [1] In HepG2 cells, high concentrations of Norswertianolin (0~150 μM) were able to increase the expression level of CSE protein. [2]
In vivo	Animal experiments showed that Norswertianolin (4.4 mg/kg/day, subcutaneous injection for one week) improved CSE/H₂S production and attenuated renal tubular injury induced by acute ischemia/reperfusion, and exerted antioxidant effects by decreasing ROS levels. In addition, it has antihypertensive, inhibits vascular remodeling and reduces inflammation. [2]

Chemical Properties

Molecular Weight	422.34
Formula	C₁₉H₁₈O₁₁
Cas No.	54954-12-0
Smiles	O(C1=C2C(OC=3C(C2=O)=C(O)C=C(O)C3)=C(O)C=C1)[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O

Storage & Solubility Information

Storage

keep away from direct sunlight,keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 20 mg/mL (47.36 mM), Sonication is recommended.

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.74 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	2.3678 mL	11.8388 mL	23.6776 mL	118.3880 mL
5 mM	0.4736 mL	2.3678 mL	4.7355 mL	23.6776 mL
10 mM	0.2368 mL	1.1839 mL	2.3678 mL	11.8388 mL
20 mM	0.1184 mL	0.5919 mL	1.1839 mL	5.9194 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc